Publications:

Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion-Positive Lung Cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Lin, Jessica J JJ; Choudhury, Noura J NJ; Yoda, Satoshi S; Zhu, Viola W VW; Johnson, Ted W TW; Sakhtemani, Ramin R; Dagogo-Jack, Ibiayi I; Digumarthy, Subba R SR; Lee, Charlotte C; Do, Andrew A; Peterson, Jennifer J; Prutisto-Chang, Kylie K; Malik, Wafa W; Hubbeling, Harper G HG; Langenbucher, Adam A; Schoenfeld, Adam J AJ; Falcon, Christina J CJ; Temel, Jennifer S JS; Sequist, Lecia V LV; Yeap, Beow Y BY; Lennerz, Jochen K JK; Shaw, Alice T AT; Lawrence, Michael S MS; Ou, Sai-Hong Ignatius SI; Hata, Aaron N AN; Drilon, Alexander A; Gainor, Justin F JF

Publication Date: 2021-05-15

Variant appearance in text: NF1: E1516D

PubMed Link: 33685866

Variant Present in the following documents:

• Main text

View BVdb publication page

Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLC.

Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer

Dagogo-Jack, Ibiayi I; Rooney, Marguerite M; Nagy, Rebecca J RJ; Lin, Jessica J JJ; Chin, Emily E; Ferris, Lorin A LA; Ackil, Jennifer J; Lennerz, Jochen K JK; Lanman, Richard B RB; Gainor, Justin F JF; Shaw, Alice T AT

Publication Date: 2019-05

Variant appearance in text: NF1: E1516D

PubMed Link: 30664990

Variant Present in the following documents:

• Main text

View BVdb publication page